Govt blocks 232 betting, loan apps; Global Pharma halts eyedrop production; DRI moves SC in Adani over-invoicing case; a Rs 1,200 crore luxury home deal

6 February, 20231 min
0
Govt blocks 232 betting, loan apps; Global Pharma halts eyedrop production; DRI moves SC in Adani over-invoicing case; a Rs 1,200 crore luxury home deal

You may also like

Internet
Story image

Why SoftBank has shunned India

For one of the world’s largest and shrewdest investors to entirely skip putting money in the country is a sign of how quickly the nature of the Indian startup ecosystem has changed.

Internet
Story image

As its core weakens, Groww looks elsewhere

Ropes in US-based State Street as an investor in its AMC business—part of a diversification drive into longer-term growth lines.

Internet
Story image

How HealthKart pulled off a D2C pivot to success and profits

In a winner-take-all market, horizontal e-commerce companies should have decimated HealthKart’s reason to exist. In a remarkable turn of events, not only has the company persisted but it is also growing and profitable.